DURHAM, N.C., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...
Infants with various forms of congenital heart disease require a stable source of blood flow to their lungs in order to survive until a more definitive operation can be performed. In a recent study, ...
Have you heard of a Blalock-Thomas-Taussig shunt for rerouting subclavian arterial blood to the lungs as palliation for cyanotic congenital heart disease (CHD)? But the BT shunt would never have seen ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback